Early Phase Cancer Immunotherapy
Springer International Publishing (Verlag)
978-3-319-63756-3 (ISBN)
Razelle Kurzrock, MD, is Senior Deputy Director for Clinical Science, Chief, Division of Hematology & Oncology, Murray Professor of Medicine, Director, Center for Personalized Cancer Therapy & Clinical Trials Office, University of California, San Diego. Sandip Patel, MD, is Assistant Professor, Cancer Immunotherapy Program, Experimental Therapeutics (Phase 1 Program), Thoracic Oncology, Division of Hematology & Oncology and Center for Personalized Cancer Therapy, UC San Diego Moores Cancer Center.
Chapter 1 Primer on Cancer Immunotherapy and the Targeting of Native Proteins.- Chapter 2 Pharmacokinetics and Pharmacodynamics of Immunotherapy.- Chapter 3 Immunotherapeutic Biomarkers and Selection Strategies.- Chapter 4 Radiographic Evaluation of Immunotherapy.- Chapter 5 Cellular Therapy.- Chapter 6 Combinatorial Checkpoint Blockade Immunotherapy and Radiation.- Chapter 7 Early Phase Cancer Immunotherapy.- Chapter 8 Immune Checkpoint Combinations with Inflammatory Pathway Modulators.- Chapter 9 Combinations of Genomically and Immune-Targeted Therapies in Early-Phase Clinical Trials.- Chapter 10 Thoracic Immunotherapy.
Erscheinungsdatum | 23.11.2017 |
---|---|
Reihe/Serie | Current Cancer Research |
Zusatzinfo | XI, 331 p. 24 illus., 15 illus. in color. |
Verlagsort | Cham |
Sprache | englisch |
Maße | 155 x 235 mm |
Gewicht | 678 g |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
Medizin / Pharmazie ► Studium | |
Schlagworte | Biomarker-selection • Cancer Research • Histology • immunotherapy • Medical Research • Medicine • Oncology • Pseudoprogression • Toxicity |
ISBN-10 | 3-319-63756-8 / 3319637568 |
ISBN-13 | 978-3-319-63756-3 / 9783319637563 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich